Article
Antisense Oligonucleotides: Treatment Strategies and Cellular Internalization
7 Nov 2016
Abstract excerpt
The clinical applicaton of antisense oligonucleotides (ASOs) is becoming more of a reality as several drugs have been approved for the treatment of human disorders and many others are in various phases in development and clinical trials. ASOs are short DNA/RNA oligos which are heavily modified to increase their stability in biological fluids and retain the properties of creating RNA-RNA and DNA-RNA duplexes that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
